The diagnostics firm reported second-quarter earnings exceeding expectations by $0.30 per share and revenue growth of 10.1% year-over-year.
Quest Diagnostics posted Q2 non-GAAP earnings per share of $3.12, surpassing estimates by $0.30. Revenue reached $3.04 billion, up 10.1% from the same period last year and $70 million above forecasts.
The company updated its full-year 2026 outlook, now projecting revenues between $11.95 billion, compared to a prior consensus of $11.85 billion. Earnings per share consensus for the year stands at $10.77.
Shares showed limited immediate reaction following the release.